Today's Date: March 26, 2023
HYZON MOTORS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers   •   Build community with shared future, create better world   •   Early Education Leadership Conference in Hershey Brings Together Hundreds of Child Advocates   •   SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Stanley Black & Decker, Inc. with Losses of $100,000 t   •   National University Receives 2023 Military Friendly® Gold Designation   •   SAMARITAN'S PURSE RUSHING HELP TO FAMILIES IMPACTED BY DEADLY TORNADOES IN MISSISSIPPI   •   Dr. Kelli Ward and Martha Boneta Fain join the advisory board of Legacy PAC, a partner of Veterans for Trump   •   Here Comes Bunnysaurus Rex Hopping Down the Dinosaur Trail   •   ARGO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Argo B   •   SOTERA HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Los   •   Philadelphia Works Names First Female Chief Operating Officer   •   Statement from the Chief Public Health Officer of Canada on World TB Day   •   GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Office   •   ImmunoGen Presents Final Overall Survival and Additional Efficacy Data from the SORAYA Trial at SGO Annual Meeting   •   DISH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DISH Network Corporatio   •   Atlanta Housing, Residents Celebrate 102nd Birthday of Clara "Mama" Bridges   •   Jennifer S. Wilkov Finalizes Lineup for the 2023 April Speak Up Women Conference   •   SOTERA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sote   •   AI-Powered Stylitics Launches Latest Platform with First-of-Its-Kind Automated Styling Technology for Retailers   •   30+ Health Leaders Explore Strategies to Ease Hospital-to-Home Patient Transitions
Bookmark and Share

Top Discoveries from a Record-Breaking Year for Cincinnati Children's

Top Discoveries from a Record-Breaking Year for Cincinnati Children's

PR Newswire

More than $283M in grants and gifts fuel research accomplishments including new ways to make organoids, detecting infant-protecting super antibodies, predicting adult heart disease risk during childhood, and more.

CINCINNATI, Feb. 8, 2023 /PRNewswire/ -- Even as research teams raced to study new vaccines and understand the potential impact of long-term COVID-19 symptoms, experts at Cincinnati Children's Hospital Medical Center made important discoveries during fiscal 2022 on a wide range of child health conditions including mental health, cancer, and many other diseases. 

The latest Research Annual Report from Cincinnati Children's, one of the world's top pediatric academic medical centers.

The latest Research Annual Report from Cincinnati Children's reflects the breadth and depth of scientific exploration occurring at one of the world's top pediatric academic medical centers, where thousands of faculty, staff, and students collaborate with families and community partners to improve child health. 

The six most significant discoveries featured this year include producing the most complex stomach organoid to date, working with colleagues in Uganda to improve outcomes for children with rheumatic heart disease, revealing the untapped potential of antibodies produced during pregnancy, advancing our understanding of muscular dystrophy, uncovering a rapid immune reaction system that may transform allergy treatment for many, and demonstrating that adult cardiovascular risks can be detected—and potentially reduced—during childhood. 

"These discoveries and all the advances featured here reflect the dedication of our exceptionally talented faculty, lab teams and research collaborators, who actively push discoveries forward to improve child health, each and every day," says Tina Cheng, MD, MPH, director of the Cincinnati Children's Research Foundation, chair of Pediatrics at the University of Cincinnati, and chief medical officer for Cincinnati Children's Hospital Medical Center. 

View the full report online. Learn more about these breakthrough discoveries: 

'Super' Antibody Discovery Opens Doors for New Vaccines, Therapies 

An eye-opening study, published in Nature, reveals how the early days of mother-to-newborn immunity actually work. The findings suggest that researchers may be able to mimic amped-up antibodies produced by expecting mothers to create new drugs and vaccines to prevent a wide range of infectious diseases. 

Novel Approach Generates Most Complex Stomach, Esophagus Organoids to Date 

Using a new, three-layered assembly approach, scientists at Cincinnati Children's report success at developing a stomach organoid so sophisticated that it has distinct glands and nerve cells that can control smooth muscle contractions. The study, published in Cell Stem Cell, reflects the latest in a string of organoid medicine breakthroughs achieved at Cincinnati Children's. 

Five Childhood Risk Factors Predict Risk of Adult Cardiovascular Events 

Cincinnati Children's scientists played central roles in a massive international study that tracked more than 38,000 people across decades to measure how closely childhood signs of heart disease risk predicted actual adult heart conditions. They found five risk factors that count, and report that taking early steps to address those risks can pay off later in life. Findings were published in The New England Journal of Medicine

Two-Hit Model of Muscular Dystrophy May Re-Direct Hunt for Cures 

For most people, muscle injury healing is spurred along by muscle satellite cells that function to regenerate the tissue. But for people with muscular dystrophy, those satellite cells actually contribute to muscle wasting, according to findings published in Nature Communications. 

In Uganda, Rheumatic Heart Disease Research Reaches its GOAL 

While rare in the United States, more than 40.5 million people globally are living with rheumatic heart disease, and more than 306,000 people die each year from a condition that starts from seemingly minor strep throat infections. Now, results from the GOAL trial in Uganda, published in the New England Journal of Medicine, show that low-cost penicillin treatments can sharply reduce latent rheumatic heart disease progression. 

Targeting RipIL-33 Pathway Could Transform Allergy Treatment 

The unexpected discovery of a built-in rapid reaction system that triggers inflammatory responses when people are exposed to allergens from insects, mites and fungi, may solve a mystery that has puzzled immunologists for years. The result could be a new wave of improved treatments to stop allergic inflammatory reactions, according to findings published in Nature Immunology

PDF of the Research Annual Report available upon e-mail request 


Cision View original content to download multimedia:

SOURCE Cincinnati Children's Hospital Medical Center

Back to top
| Back to home page

White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News